patents – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

CCG > Outreach activities > Collaborations > patents

Patents

USP 7,381,554 

UDP-N-acetylglucosamine: galactoseβ1,3-N-acetylgalactosamineα-R/N-acetylglucosamineβ1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc)β1,6-N-acetylglucosaminyltransferase, C2/4GnT  

USP 7,374,919 

UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase,β4Gal-T2 

USP 7,338,933 

O-linked glycosylation of peptides 

USP 7,338,932 

Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments 

USP 7,332,279 

UDP-galactose: β-N-acetyl-glucosamine β1,3 galactosyltransferases,β3Gal-T5 

USP 7,241,282 

Compositions and methods for prolonging survival of platelets 

USP 7,115,404 

UDP-galactose: β-D-galactose-R 4-α-D-galac-tosyltransferase, α4Gal-T1  

USP 7,097,994 

UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GalNAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 

USP 7,094,887 

UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 

USP 7,078,206 

UDP-N-acetylglucosamine: galactose-β1, 3-N-acetylgalactosamine-α1-R/(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 

USP 6,995,004 

UDP-N-acetylglucosamine: galactose-β-1,3-N-acetylgalactosamine-α-R / N- acetylglucosamine β-1,3,-N-acetylgalactosamine-α-R (GlcNAc to GalNAc)β1,6-N-acetylglucosaminyltransferase, C2/4GNT 

USP 6,916,649 

UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyltransferase, β4Gal-T2 

USP 6,800,468 

UDP-Galactose: β-N-acetylglucosamine β1,3galactosyltransferase,β3Gal-T5 

USP 6,794,169 

UDP-N-acetylglucosamine: galactose-β1, 3-N-acetylgalactosamine-α1-R/(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 

USP 6,635,461 

UDP-N-acetylglucosamine: galactose-β1, 3-N-acetylgalactosamine-α1-R/(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 

USP 6,558,934 

UDP-galactose: β-N-acetyl-glucosamine β-1,4-galactosyl-transferase,β4Gal-T2 

USP 6,465,220 

Glycosylation using GalNAc-T4 transferase 

USP 5,876,716 

Method of using an antibody to the Tn antigen for the inhibition of HIV infection 

USP 5,871,990 

UDP-N-acetyl-α-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase, GalNAc-T3 

USP 5,747,048 

Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates 

USP 5,660,834 

Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates 

USP 5,421,733 

Synthesis of Lex ; dimeric Lex (difucosyl Y2 ; III.sup.3 FucV.sup.3 FucnLc.sub.6 Cer); sialylated forms thereof; and analogues thereof 

USP 5,418,129 

Blood treatment method 

USP 5,326,857 

ABO genotyping 

USP 5,240,833 

Method for the production of monoclonal antibodies directed to tumor-associated gangliosides and fucogangliosides 

USP 5,229,289 

Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates 

USP 5,068,191 

Purified histo-blood group A glycosyltransferase and antibodies thereto 

USP 4,942,224 

 A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing 

USP 4,857,639 

A-associated H-antigens, monoclonal antibodies specific thereto and methods for employing the same in blood typing